v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities:    
Net loss $ (116,707) $ (77,720)
Adjustments to reconcile net loss to net cash used in operating activities    
Depreciation and amortization 637 752
Non-cash loss on sale of property and equipment 137 0
Net (accretion) of investments in marketable securities (370) (324)
Non-cash lease expense 1,785 1,461
Stock-based compensation expense 21,799 13,164
Changes in operating assets and liabilities:    
Accounts receivable (171) 0
Prepaid expenses and other current assets (3,199) (2,610)
Other assets 344 (910)
Accounts payable (2,463) 1,037
Accrued expenses and other current liabilities 4,154 2,480
Operating lease liabilities (2,095) (102)
Net cash used in operating activities (96,149) (62,772)
Cash flows from investing activities    
Purchases of short-term investments (84,439) (157,713)
Sale of short-term investments 10,075 0
Maturities of short-term investments 188,732 145,011
Purchases of property and equipment (164) (447)
Proceeds from sales of equipment 401 0
Net cash provided by (used in) investing activities 114,605 (13,149)
Cash flows from financing activities    
Proceeds from underwritten public offering, net of underwriter discounts and commissions and deferred offering costs 0 269,834
Payment of deferred offering costs (453) 0
Proceeds from exercise of stock options 4,111 642
Repurchase of unvested restricted common stock (5) (1)
Net cash provided by financing activities 3,653 270,475
Net increase in cash, cash equivalents, and restricted cash 22,109 194,554
Cash, cash equivalents, and restricted cash at beginning of period 52,750 56,910
Cash, cash equivalents, and restricted cash at end of period 74,859 251,464
Supplemental disclosure for noncash investing and financing activities:    
Right-of-use assets obtained in exchange for operating lease liabilities 0 10,499
Deferred offering costs included in accounts payable and accrued expenses at period end 36 394
Purchases of property and equipment included in accounts payable and accrued expenses at period end 11 65
Reconciliation of cash, cash equivalents and restricted cash    
Cash and cash equivalents 74,754 251,359
Restricted cash 105 105
Total cash, cash equivalents and restricted cash shown in the statement of cash flows $ 74,859 $ 251,464